Diffuse cutaneous systemic sclerosis (dcSSc) is a subtype of systemic sclerosis characterised by widespread skin thickening and early visceral involvement, particularly affecting the lungs, heart, and kidneys. Its clinical significance lies in the rapid progression of organ damage, which can lead to severe complications such as pulmonary fibrosis and renal crisis. Early recognition and management are crucial to improving patient outcomes and preventing morbidity associated with this aggressive form of scleroderma.